NAII's liquidation posture as of December 31, 2025 is deeply negative, consistent with the MFFAIS-reported CLV of -$73.9M. Total assets of $153.3M against total liabilities of $86.3M yields reported book equity of $67.0M, but applying liquidation haircuts collapses recovery sharply. Cash of $3.8M recovers at par, but all of it is held by the Swiss subsidiary NAIE—creating a repatriation friction (5% Swiss withholding on dividends) that reduces effective recovery. AR at $17.8M gross (zero allowance per XBRL) applies at ~90-95%, recovering approximately $16-17M. Inventory of $33.4M (net of $574K reserve) applies a 60% haircut, yielding roughly $20M—inventory build of $8.6M cash outflow in H1 FY2026 is the single largest operating cash drain this period and represents a rising exposure. PP&E gross of $109.3M with $58.0M accumulated depreciation gives net book of $51.3M; at 50-70% recovery that yields $26-36M. The ROU asset of $39.8M is zero-value on liquidation while the corresponding operating lease liabilities of $47.1M ($2.3M current + $44.8M noncurrent) remain at face value—this asymmetry alone consumes approximately $39.8M of apparent asset value relative to the balance sheet presentation. Intangibles and other noncurrent assets receive zero to negligible recovery. The resulting liquidation value to equity is solidly negative, consistent with the reported metrics. Key deterioration since the prior filing (Q1 FY2026, September 30, 2025): inventory has grown materially (cash used $8.6M in H1 vs. $1.2M provided in prior-year H1), line of credit draws increased from $2.5M at September 30 to $5.8M at December 31, and cash dropped from $7.7M to $3.8M (with essentially all cash offshore at NAIE). The credit facility with Wells Fargo matures December 31, 2026; the company is in covenant default as of December 31, 2025, has obtained a waiver for Q2 FY2026 but does not expect compliance in Q3 FY2026, and is concurrently negotiating with a potential new ABL lender. A $1.25M employment litigation settlement is pending court approval but was accrued at June 30, 2025. The valuation allowance against U.S. domestic net deferred tax assets ($5.5M gross, fully reserved) is now complete, eliminating any DTA recovery value. Operating cash burn is accelerating: -$10.4M in H1 FY2026 vs. -$3.4M in H1 FY2025. Management has guided to a full-year FY2026 net loss, a reversal of prior guidance for H2 profitability. Filing discusses the $1.25M litigation settlement accrual and ERTC receivable (approximately $600K remaining for Q3 2021 claim still contested by IRS) in MD&A but the ERTC receivable is not separately tagged in XBRL—it is embedded within IncomeTaxesReceivable of $118K, which appears inconsistent with the disclosed amount; the residual claim may be carried elsewhere or already written off.
▼ Community Notes